scholarly journals Prevalence and factors associated with continual opioid use among patients attending methadone clinic at Mwananyamala Hospital, Dar Es Salaam, Tanzania

2019 ◽  
Vol 1 ◽  
pp. 100037
Author(s):  
Asha Shabani Ripanda ◽  
Bajarang Bal Lal Srivastava ◽  
Said Hamad Vuai ◽  
Azan A Nyundo
2020 ◽  
Vol 158 (6) ◽  
pp. S-1463
Author(s):  
Dhruvil Radadiya ◽  
Karolina N. Dziadkowiec ◽  
Kalpit H. Devani ◽  
Paris Charilaou ◽  
Chakradhar M. Reddy

2013 ◽  
Vol 28 ◽  
pp. 1
Author(s):  
H. Zakaria ◽  
S.A. Mohd Yusof ◽  
M. Midin ◽  
A.K. Abu Bakar ◽  
H. Md Yusof ◽  
...  

2004 ◽  
Vol 10 (1-2) ◽  
pp. 82-89
Author(s):  
V. Rahimi Movaghar ◽  
F. Rakhshaei ◽  
M. Mohammadi ◽  
A. Rahimi Movaghar

To study the prevalence and factors associated with opioid use in pain, 480 consecutive patients with a chief complaint of pain were interviewed at 10 clinics in Zahedan. The data were analysed in relation to 18 possible associated factors. The prevalence of opioid use was 28.5% in patients presenting with pain. There was no significant relation between opioid use and chronic pain [>/= 6 months], but there was a relationship with the following 5 factors:previous opioid use by friends [72.9% versus 20.4% without friends using], occupation [58.5% private sector employees/self-employed versus 17.4% housewives], cigarette smoking [60.8% versus 21.8% not smoking], consultation for a psychological problem [38.3% versus 23.3% without], and death of a spouse [60.0% versus 26.1% without]


2018 ◽  
Vol 52 (5) ◽  
pp. 405-414 ◽  
Author(s):  
Natalia Shcherbakova ◽  
Gary Tereso ◽  
Jacqueline Spain ◽  
Robert J. Roose

Background: Persistence with medication-assisted therapy among patients with opioid use disorder has been associated with reduced likelihood of illicit opioid use. Objective: We aimed to describe treatment persistence and identify factors associated with 1-year persistence among insured patients newly initiating buprenorphine-containing pharmacotherapy. Methods: The retrospective observational cohort included employer-sponsored and managed Medicaid patients newly started on buprenorphine-containing therapy between June 30, 2010, and January 1, 2015. Persistence was measured as both a continuous and dichotomous variable (proportion of patients persistent for 1 year). Multivariable logistic regression analysis was used to identify factors associated with 1-year persistence. Results: A total of 302 patients met inclusion criteria. The median [range] number of treatment episodes was 1 [1-4]. Mean number of days on therapy during the first episode was 206 (SD = 152) days, with 40.4% (n = 122) of patients persisting for 1 year. Presence of concomitant fills of prescription opioid analgesics (odds ratio [OR] = 0.25; 95% CI = 0.12-0.51), being in care of an addiction specialist (OR = 0.40; 95% CI = 0.21-0.76), and Medicaid insurance coverage (OR = 0.33; 95% CI = 0.13-0.84) were significantly and negatively associated with 1-year persistence. There was also a strong inverse relationship between persistence and inpatient hospitalization (OR = 0.30; 95% CI = 0.12-0.76). Conclusions: Several health care delivery and use variables were significantly associated with nonpersistence. Concomitant use of prescription opioids is the most easily modifiable risk factor that health care providers and policy makers may act on to improve treatment continuation.


2018 ◽  
Vol 131 ◽  
pp. 196S
Author(s):  
Michael Cohen ◽  
Erica Weston ◽  
Christina Raker ◽  
David Huang ◽  
Cara Mathews

2019 ◽  
Vol 7 (7_suppl5) ◽  
pp. 2325967119S0025
Author(s):  
Anita G. Rao ◽  
Heather A. Prentice ◽  
Priscilla Hannah Chan ◽  
Liz W. Paxton ◽  
Tadashi Ted Funahashi ◽  
...  

Objectives: The misuse of opioid medication has contributed to a significant national crisis affecting public health, as well as patient morbidity and medical costs. We sought to determine baseline opioid utilization in patients undergoing ACLR and examine demographic, patient characteristics, and medical factors associated with postoperative opioid utilization. Methods: Primary elective ACLR were identified using an integrated healthcare system’s ACLR registry (January 2005-January 2015). Patients with cancer or those who had other knee surgery in the preceding year were excluded. We studied the effect of preoperative and intraoperative risks factors on number of dispensed opioid medication prescriptions (Rx) in the early (0-90 days) and late (91-360 days) postoperative periods using logit regression. Risk factors studied included: number of opioid Rx in preceding year, age, gender, race, American Society of Anesthesiologists (ASA) classification, body mass index (BMI), activity at the time of injury, time from injury to ACLR, concomitant procedure or injury, medical comorbidities, and opioid-use comorbidities. Results: Of 21202 ACLR from 20813 patients, 25.5% used at least 1 opioid Rx in the one-year preoperative period. 17.7% and 2.7% used ≥2 opioid Rx in the early and late recovery periods, respectively. The risk factors associated with greater opioid Rx in both the early and late periods included: preoperative opioid use, age >20 years, ASA classification of ≥3, other activity at the time of injury, repaired cartilage injury, chronic pulmonary disease, and substance abuse. Risk factors associated with opioid Rx use during the early period only included: other race, acute ACL injury, repaired meniscal injury, multi-ligament injury, and dementia/psychoses. Risk factors associated with greater opioid Rx during the late period included: female gender, BMI >25 kg/m2, motor vehicle accident as the mechanism of injury, and hypertension. Conclusion: We identified several risk factors for postoperative opioid usage after ACLR. The strongest predictors of postoperative prescription opioid usage after ACLR included preoperative opioid use, increasing age, ASA classification of 3 or more, other activity at the time of injury, repaired meniscal injury, cartilage repair, chronic pulmonary disease, and substance abuse. Awareness of risk factors for postoperative opioid usage may encourage more targeted utilization of opioids in pain management. Surgeons may consider additional support or referral to a pain specialist for patients with these risk factors. [Figure: see text]


Sign in / Sign up

Export Citation Format

Share Document